Cabaletta Bio: Executive Compensation Details Revealed
Ticker: CABA · Form: DEF 14A · Filed: May 13, 2025 · CIK: 1759138
Sentiment: neutral
Topics: executive-compensation, sec-filing, equity-awards
Related Tickers: CABA
TL;DR
Cabaletta Bio dropped its 2023 exec comp details - check out those equity awards!
AI Summary
Cabaletta Bio, Inc. filed a DEF 14A on May 13, 2025, detailing executive compensation for the fiscal year ending December 31, 2023. The filing includes information on equity awards granted to its "PEO" (Principal Executive Officer) and "Non-PEO Neo" members, outlining the change in fair value of outstanding awards and those vesting during the year.
Why It Matters
This filing provides transparency into how Cabaletta Bio compensates its top executives, which can influence investor perception and the company's ability to attract and retain talent.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures about executive compensation and corporate governance, but can sometimes reveal information that impacts stock price.
Key Players & Entities
- Cabaletta Bio, Inc. (company) — Filer of the DEF 14A
- 2023-12-31 (date) — Fiscal year end for compensation data
- 20250513 (date) — Filing date
FAQ
What is the primary purpose of this DEF 14A filing for Cabaletta Bio, Inc.?
The primary purpose is to disclose information regarding the compensation of the company's top executives and directors for the fiscal year ending December 31, 2023.
What specific types of compensation are detailed in the filing?
The filing details equity awards, including the change in fair value of outstanding and unvested equity awards granted to PEO and Non-PEO Neo members.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted on May 13, 2025.
What is the fiscal year end date for the compensation data presented?
The fiscal year end date for the compensation data presented is December 31, 2023.
Who are the main categories of individuals whose compensation is detailed?
The compensation details are broken down for "PEO" (Principal Executive Officer) and "Non-PEO Neo" members.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 13, 2025 regarding Cabaletta Bio, Inc. (CABA).